PANTHERx® Specialty Pharmacy announced today that it has entered into a partnership with The Health Plan as a provider of specialty pharmacy medications across multiple therapeutic categories. In addition, PANTHERx® will be the exclusive provider for the recently FDA-approved therapies CRYSVITA® (burosumab-twza) injection and JYNARQUE™ (tolvaptan).

Through this partnership, The Health Plan and PANTHERx both desire to preserve and enhance patient dignity and the tenets of managed care, apply cost containment methods and practices, and provide the highest quality of care to members.

“We at The Health Plan look forward to our new partnership with PANTHERx® to improve access and quality of care for our ever-growing patient population,” said J. Neal Ford, Pharm.D., Clinical Pharmacist and head of non-governmental pharmacy operations at The Health Plan.

“We are very excited about the opportunity to partner with The Health Plan and provide the highest quality of care for their members,” said David Stasiowski, Vice President, Business Development & Managed Markets at PANTHERx®.

About The Health Plan

“The Health Plan, established in 1979, is one of the largest locally managed care organizations in Ohio and West Virginia, serving over 200,000 covered lives. As a federally qualified and state certified 501 (c)(4) not-for-profit HMO, our goal is to provide high quality, comprehensive, and cost-effective health care. The Health Plan is an established and financially secure organization and West Virginia’s first and largest HMO.